News Demant A/S Berne S.E.

Equities

Delayed Berne S.E. Other stock markets 10:30:03 15/11/2023 pm IST			5-day change	1st Jan Change
34.92 ^CHF	-.--%		-19.92%	-6.81%

26/06	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT
29/05	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT

Demant Flags Delay in Completion of Communications Business' Strategic Review	26/06	MT
Demant A/S: Updated timeline for the strategic review of Communications	26/06	AQ
UK’s Competition Regulator Closes Cochlear-Demant Deal	29/05	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	21/05	MT
Demant A/S: Closing of divestment of cochlear implants business	21/05	AQ
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	21/05	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	06/05
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	06/05
Hearing Healthcare Company Demant Affirms FY24 Outlook	06/05	MT
Demant A/S: Interim Management Statement for Q1 2024	06/05	AQ
Demant A/S Provides Earnings Guidance for the Year 2024	06/05	CI
Denmark's Demant Finalizes Capital Reduction	08/04	MT
Demant A/S: Completion of capital reduction in Demant A/S	08/04	AQ
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04/04	MT
Demant Seeks Acquisitions	12/03	CI
Transcript : Demant A/S - Analyst/Investor Day	12/03
Demant A/S: Capital Markets Day 2024 - Sharpened focus on Hearing Healthcare	12/03	AQ
Demant A/S: Decisions of Annual General Meeting	06/03	AQ
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	28/02	DJ
Demant A/S: Transactions with Demant shares by Board of Directors and Executive Board and closely related parties	28/02	AQ

No results for this search

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 08:48 pm IST